Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-19

FDA Approved: DARIFENACIN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for darifenacin (generic) by Rising Pharma Holdings, Inc. for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Darifenacin (darifenacin)

Snippet

ORIG AP for DARIFENACIN (DARIFENACIN)